Mon-Sun: 9.00 AM - 6.00 PM
+919696097866 /+912512400397

CDSCO Update on Biopharmaceutical systems

CDSCO Update on Biopharmaceutical systems

CDSCO has released the ninth amendment in Drug and Cosmetics rules on April 03, 2017

CDSCO has made following changes in Drug and Cosmetics rules, 1945 as G.S.R 327 (E)

  1. In D & C rule, 1945, in rule 2 after clause (a), CDSCO has given classification of biopharmaceutical system based on solubility and permeability of drugs. They are as follows category I- high solubility and high permeability, category II- low solubility and high permeability, category III- high solubility and low permeability, and category IV- low solubility and low permeability.
  2. In rule 74, after clause (p), clause (q), In rule 74B, after clause (7), clause (8), In rule 76, after clause (9), clause (10), In rule 78, after clause (q), clause (r), In rule 78A, after clause (8), clause (9) following clause has been added “The applicant shall submit the result of bioequivalence study referred to in Schedule Y, along with the application for grant of a license of oral dosage form of drugs specified under category II and category IV of the biopharmaceutical classification system.”

Click here for Full Guideline

Subscribe to newsletter

Send reply to this news

The technical inputs, quality of work and translation output provided by M/s. InClinition, Dombivli, Mumbai, India were found satisfactory and meeting the latest standards. We recommend them for any kind of translation projects in future.

Dr. Ashish Mungantiwar
Dr. Ashish MungantiwarPresident-Medical Services, Mcleods Pharmaceuticals Ltd.

We found their suggestions and guidelines appropriate to our formulation range. InClinition Team has expert domain knowledge. They involved all our staff during conduction of audit and created positive approach towards audit. We strongly recommend their services and wish a continued support from them.

Mr. Nandkishor Deshpande
Mr. Nandkishor DeshpandeDirector, Debco Homeopathic Pharmaceuticals

On occasion of InClinition's 1st International Scientific Conference, we wish a grand success to conference.

Mr. Pranab Mukherjee
Mr. Pranab MukherjeePresident, Republic of India
Phone: +919696097866 /+912512400397
Corporate office: 91Springboard Lotus, Plot No.5, Road No.20, Marol MIDC, Andheri (East)-400069, Mumbai, India
Registered Office: S2/3, Shri Devdoot, Phule Road, Dombivli (West), Mumbai, India